CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 49 enrolled
Drug / intervention
AMAZE™ Application +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04868500
NCT04868500N/ACompleted
CompareCT.gov

Managing Asthma Patients With AMAZE™: A Novel Disease Management Platform, A Clinical Pilot Study

AstraZeneca·interventional·Posted May 3, 2021·Updated Feb 8, 2023

In Brief

A clinical study evaluating AMAZE™ Application and AMAZE™ Dashboard for Asthma. Completed, enrolled 49 participants across 1 site.

Detailed Summary

The primary study objective is to generate evidence as to the feasibility, usability, perceived value, and potential benefits of implementing the AMAZE™ platform into clinical practice.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesUnited States
CollaboratorsMassachusetts General Hospital, Evidera

Timeline

N/ACompletedFinished
20222023202420252026
First PostedMay 3, 2021
Enrollment StartApr 27, 2021
Primary CompletionNov 30, 2021
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 5.2 years ago

Interventions

AMAZE™ Applicationdevice

Participants will use the AMAZE™ application to enter daily asthma symptoms and impact to communicate this information to their healthcare provider, as well as access disease educational materials up to six months.

AMAZE™ Dashboarddevice

Clinical site staff will use the AMAZE™ dashboard for six months to identify usability and barriers, benefits, challenges, ease of implementation, and areas for improvement of the AMAZE™ dashboard in a clinical setting.